Serologic Evaluation of Healthcare Workers Caring for COVID-19 Patients in the Republic of Korea
Authors:
Open Access
- 20 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11, 587613
Abstract
The safety of healthcare workers (HCWs) against severe acute respiratory syndrome virus 2 (SARS-CoV-2) transmission is an important aspect of managing the coronavirus disease 2019 (COVID-19) pandemic. In the South Korea, highly stringent infection prevention and control (IPC) guidelines are implemented, and reports of healthcare-associated SARS-CoV-2 transmission among HCWs are limited. However, subclinical infections may have been missed by the current symptom-based screening strategy. To evaluate the risk of undetected SARS-CoV-2 transmissions from COVID-19 patients to HCWs, we conducted a multicenter seroprevalence study after the first surge of the COVID-19 outbreak. A total of 432 HCWs were evaluated, comprising 309 HCWs designated to laboratory-confirmed COVID-19 patient care and 123 non-designated HCWs. Designated HCWs wore personal protective equipment including an N95 respirator, eye protection, hooded overalls, shoe covers, and inner and outer gloves. Use of a powered air-purifying respirator was recommended for aerosol-generating procedures or long-duration care activities. A high-sensitivity (99.1%) fluorescence immunoassay immunoglobulin G (IgG) kit was used as the initial screening test, and two enzyme-linked immunosorbent assay kits for total and IgG antibodies were used to confirm the test results. A microneutralization test was additionally performed to evaluate the neutralizing activity of positive specimens. Among the evaluated HCWs, none of the non-designated HCWs had a positive result, while one of the HCWs designated for COVID-19 patient care (1/309, 0.3%) was seropositive for SARS-CoV-2 with confirmed neutralizing activity (1:40). This finding suggests that subclinical seroconversion may occur among HCWs caring for COVID-19 patients, although the risk is low under strict IPC guidance.Keywords
Funding Information
- Korea Centers for Disease Control and Prevention
This publication has 16 references indexed in Scilit:
- SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patientsJournal of Clinical Virology, 2020
- Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York CityJournal of General Internal Medicine, 2020
- SARS‐CoV‐2 Infection in Health Care Workers: Cross‐sectional Analysis of an Otolaryngology UnitOtolaryngology–Head and Neck Surgery, 2020
- Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmissioneLife, 2020
- Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020Journal of Korean Medical Science, 2020
- Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis CAnnals of Laboratory Medicine, 2018
- Serologic Evaluation of MERS Screening Strategy for Healthcare Personnel During a Hospital-Associated OutbreakInfection Control & Hospital Epidemiology, 2016
- Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in KoreaAnnals of Internal Medicine, 2016
- Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological studyThe Lancet Infectious Diseases, 2015
- Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare FacilitiesInfection & Chemotherapy, 2015